Jan Pawlas
6 Papers
3 Citations
Jan Pawlas is an academic researcher. The author has contributed to research in topics: Peptide synthesis & Chemistry. The author has an hindex of 4, co-authored 6 publications.
Chat about Author
Papers
ReGreen SPPS: enabling circular chemistry in environmentally sensible solid-phase peptide synthesis
Jan Pawlas,Jon H. Rasmussen +1 more
TL;DR: The ReGreen SPPS as mentioned in this paper protocol uses polystyrene/divinylbenzene resins as polymer supports, inexpensive ethyl acetate (EtOAc) and dimethylsulfoxide (DMSO) as solvents, is synthetically efficient in terms of equivs of amino acids (AAs) in couplings and amounts of base in Fmoc removals and afforded a model difficult 10-mer peptide in 84% yield and 76% purity.
52
2D green SPPS: green solvents for on-resin removal of acid sensitive protecting groups and lactamization
TL;DR: An SPPS method for the on-resin removal of acid labile protecting groups using TFA/TIS in EtOAc/MeCN and lactamization with PyBOP/DIEA in NBP/EtOAc is reported.
39
Minimizing HCN in DIC/Oxyma-Mediated Amide Bond-Forming Reactions
Marion Erny,Marika Lundqvist,Jon H. Rasmussen,Olivier Ludemann-Hombourger,Frédéric Bihel,Jan Pawlas +5 more
TL;DR: Aiming at advancing protocols for safer, environmentally sensible peptide synthesis, findings with regard to the occurrence of hydrogen cyanide (HCN, prussic acid) in amide bond-formin are reported.
27
1,4-Benzenedimethanethiol (1,4-BDMT) as a scavenger for greener peptide resin cleavages
TL;DR: 1,4-BDMT is identified as a scavenger that affords the peptide in higher quality than the standard aliphatic thiol reagents, not least in terms of the content of critical peptide impurities in the crude material.
Sustainable, cost-efficient manufacturing of therapeutic peptides using chemo-enzymatic peptide synthesis (CEPS)
Jan Pawlas,Timo Nuijens,Jonas Persson,Thomas Svensson,Marcel Schmidt,Ana Toplak,Mikael Nilsson,Jon H. Rasmussen +7 more
TL;DR: CEPS provides a highly efficient, easily scalable biocatalytic route to manufacture therapeutic peptides for antidiabetic exenatide use.